| Name | 5'-Deoxy-5-fluorocytidine |
|---|---|
| Synonyms |
5'-deoxy-5-fluoro-Cytidine
5'-Deoxy-5-fluorocytidine MFCD07369278 Cytidine, 5'-deoxy-5-fluoro- 4-Amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydro-2-furanyl]-5-fluoro-2(1H)-pyrimidinone 5'-Deoxy-5-fluoro Cytidine Capecitabine Impurity 1 |
| Description | 5-Fluoro-5'-deoxycytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 437.9±55.0 °C at 760 mmHg |
| Melting Point | 196-198ºC |
| Molecular Formula | C9H12FN3O4 |
| Molecular Weight | 245.21 |
| Flash Point | 218.6±31.5 °C |
| Exact Mass | 245.081177 |
| PSA | 110.60000 |
| LogP | -0.94 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.700 |
| Storage condition | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| Hazard Codes | Xn: Harmful;Xi: Irritant; |
|---|---|
| Risk Phrases | R20/21/22 |
| Safety Phrases | 26-36-37/39 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2934999090 |
|
~92%
66335-38-4 |
| Literature: ANGIOGENE PHARMACEUTICALS LIMITED; THE GRAY LABORATORY CANCER RESEARCH TRUST Patent: WO2006/32921 A1, 2006 ; Location in patent: Page/Page column 37-38 ; |
|
~95%
66335-38-4 |
| Literature: MacDonald, Peter Lindsay; Rossetto, Pierluigi; Gallina, Maurizio Patent: US2009/209754 A1, 2009 ; Location in patent: Page/Page column 9-10 ; |
|
~86%
66335-38-4 |
| Literature: Procopio, Antonio; Gaspari, Marco; Nardi, Monica; Oliverio, Manuela; Romeo, Roberto Tetrahedron Letters, 2008 , vol. 49, # 12 p. 1961 - 1964 |
|
~%
66335-38-4 |
| Literature: Chinese Chemical Letters, , vol. 21, # 2 p. 163 - 166 |
|
~%
66335-38-4
Detail
|
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 40, # 9 p. 2568 - 2571 |
| Precursor 4 | |
|---|---|
| DownStream 2 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |